ABSTRACT Introduction Metabolic syndrome (MetS), ie the cluster of cardiometabolic risk
factors comprising visceral obesity, impaired glucose metabolism, arterial hypertension and …

Metabolic syndrome (MetS) has long-term, very detrimental effects, including chronic kidney
disease, cardiovascular disease, stroke, and diabetes mellitus. Therefore, early detection of …

Background: Depression is a possible influence factor for the increased risk of atrial
fibrillation (AF). Although several investigations have assessed their association, the results …

Background Patients with affective and anxiety disorders are at risk of metabolic syndrome
(MetS) and, consequently, cardiovascular disease and premature death. In this study, the …

Selective serotonin reuptake inhibitors (SSRIs) are used worldwide as the first-line
pharmacological treatment for depression. Although SSRI use can increase the risk of …

Background Depression increases the risk of cardiovascular disease (CVD). The
association between antidepressant medications (ADMs) and CVD remains controversial …

Introducción: La depresión se ha convertido en un importante problema de salud pública
mundial, debido a su prevalencia relativamente alta a lo largo de la vida, así como a la …

Background: Accumulated studies have indicated that depression was significantly
associated with the atrial fibrillation (AF) risk. However, the causal effect of major depressive …

Abstract Patients with Obstructive Sleep Apnea (OSA) experience depressive symptoms.
This thesis explored the prevalence of depressive symptoms in OSA patients and if …